Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Barclay

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Alzheimer'S Disease Reports|February 13, 2023
A Case of Minimally Progressive Prodromal Alzheimer's DiseaseMichael H Rosenbloom, Terry Barclay
Neurology. Clinical Practice|February 27, 2016
Routine cognitive screening in a neurology practice: Effect on physician behaviorMichael Rosenbloom, Soo Borson, Terry Barclay, et al.
Drugs in R&D|February 21, 2020
Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down SyndromeMichael Rosenbloom, Terry Barclay, Justin Johnsen, et al.
Frontiers in Neuroscience|December 24, 2024
Open label pilot of personalized, neuroimaging-guided theta burst stimulation in early-stage Alzheimer's diseaseBhavani Kashyap, Leah R Hanson, Sally K Gustafson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Alzheimer'S Disease Reports|February 13, 2023
A Case of Minimally Progressive Prodromal Alzheimer's DiseaseMichael H Rosenbloom, Terry Barclay
Neurology. Clinical Practice|February 27, 2016
Routine cognitive screening in a neurology practice: Effect on physician behaviorMichael Rosenbloom, Soo Borson, Terry Barclay, et al.
Drugs in R&D|February 21, 2020
Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down SyndromeMichael Rosenbloom, Terry Barclay, Justin Johnsen, et al.
Frontiers in Neuroscience|December 24, 2024
Open label pilot of personalized, neuroimaging-guided theta burst stimulation in early-stage Alzheimer's diseaseBhavani Kashyap, Leah R Hanson, Sally K Gustafson, et al.
Pageof 1